PRDM12 and colon adenocarcinoma: We also note that PRDM12 is overexpressed in 21 out of 22 colon adenocarcinoma patients (this patient cohort is not presented in our analysis because its size does not meet our criteria for statistical significance (cohort size <30 patients), but this exceptional ratio of 95% is still worth mentioning).